Jazz Challenges FDA on Lumryz Approval, Avadel Responds
Jazz Pharmaceuticals is challenging the FDA in district court over the FDA’s recent approval of a competing new narcolepsy drug, Lumryz.
Read More
Author: Alyx Arnett
Little-Known Ways to Pay for Oral Appliances
Dog eat your patient’s oral appliance? A few simple solutions can protect your patients’ sleep apnea therapy investments.
Read More
The Obvious, Unexplored Nocturia Management Strategy
The management strategy could become an effective nocturia treatment—one that extends beyond the bladder and doesn’t run the risk of side effects.
Read More
Is Tackling Chronic Pain a Prerequisite for Insomnia Treatment?
Myth or fact?: Cognitive behavioral therapy for insomnia will work only if chronic pain is first addressed.
Read More
The Surge in OTC Melatonin Use Isn’t Just Your Imagination
Why sleep specialists increasingly see patients using melatonin and how to help them.
Read More